IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Sylvia Caras <[log in to unmask]>
Reply To:
Date:
Mon, 31 Jan 2011 18:09:37 -0800
Content-Type:
text/plain
Parts/Attachments:
text/plain (26 lines)
F.D.A. Panel Is Split on Electroshock Risks - Wall Street Journal

A federal advisory panel was sharply divided on Friday about whether 
to recommend that regulators designate electroshock devices as high risk.

FDA panel advises more testing of 'shock-therapy' devices - Washington Post

An expert panel advising the Food and Drug Administration decided 
Friday that electroconvulsive therapy (ECT) machines should undergo 
the same rigorous testing as new medical devices coming onto the 
market - a decision that could drastically affect the future of 
psychiatry's most controversial treatment.

Victory: FDA Panel Votes to Require Testing of ECT Device After 
Survivors Testify at FDA Electroshock Hearing - MindFreedom

A panel for the US Food & Drug Administration voted to ask the FDA to 
require testing of the device used for electroshock.






"People Who experience mood swings, fear, voices and visions"

ATOM RSS1 RSS2